Glioblastoma Targeted Gene Therapy Based on pEGFP/p53-Loaded Superparamagnetic Iron Oxide Nanoparticles

E-ISSN： 1875-5631|17|1|59-69

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.17, Iss.1, 2017-07, pp. : 59-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6575-6593

Bentham Science Publishers

Access to resources Recommend Favorite

Magnetic Iron Oxide Nanoparticles for Tumor-Targeted Therapy

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 184-189

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53 wild–type JVM-2 But Not Towards p53 mutated BJAB Leukemic Cells

Current Medicinal Chemistry, Vol. 20, Iss. 21, 2013-07 ,pp. : 2712-2722

Bentham Science Publishers

Access to resources Recommend Favorite

Network Effect of Wt-mutant p53 Interactions and Implications on p53 Gene Therapy

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1259-1267

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle-mediated p53 gene therapy for tumor inhibition

By Sharma Blanka

Drug Delivery and Translational Research, Vol. 1, Iss. 1, 2011-02 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite